These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 22863786)

  • 1. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B.
    Sun Y; Campisi J; Higano C; Beer TM; Porter P; Coleman I; True L; Nelson PS
    Nat Med; 2012 Sep; 18(9):1359-68. PubMed ID: 22863786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment-induced secretion of WNT16B promotes tumor growth and acquired resistance to chemotherapy: implications for potential use of inhibitors in cancer treatment.
    Johnson LM; Price DK; Figg WD
    Cancer Biol Ther; 2013 Feb; 14(2):90-1. PubMed ID: 23114711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment.
    Sun Y; Zhu D; Chen F; Qian M; Wei H; Chen W; Xu J
    Oncogene; 2016 Aug; 35(33):4321-34. PubMed ID: 26751775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor microenvironment controls drug sensitivity.
    Ostman A
    Nat Med; 2012 Sep; 18(9):1332-4. PubMed ID: 22961158
    [No Abstract]   [Full Text] [Related]  

  • 5. WNT16B from ovarian fibroblasts induces differentiation of regulatory T cells through β-catenin signal in dendritic cells.
    Shen CC; Kang YH; Zhao M; He Y; Cui DD; Fu YY; Yang LL; Gou LT
    Int J Mol Sci; 2014 Jul; 15(7):12928-39. PubMed ID: 25050785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance.
    Huber RM; Lucas JM; Gomez-Sarosi LA; Coleman I; Zhao S; Coleman R; Nelson PS
    Oncotarget; 2015 Feb; 6(4):2134-47. PubMed ID: 25575823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-derived fibulin-3 activates pro-invasive NF-κB signaling in glioblastoma cells and their microenvironment.
    Nandhu MS; Kwiatkowska A; Bhaskaran V; Hayes J; Hu B; Viapiano MS
    Oncogene; 2017 Aug; 36(34):4875-4886. PubMed ID: 28414309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role for WNT16B in human epidermal keratinocyte proliferation and differentiation.
    Teh MT; Blaydon D; Ghali LR; Briggs V; Edmunds S; Pantazi E; Barnes MR; Leigh IM; Kelsell DP; Philpott MP
    J Cell Sci; 2007 Jan; 120(Pt 2):330-9. PubMed ID: 17200136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ectopic fibroblast growth factor receptor 1 promotes inflammation by promoting nuclear factor-κB signaling in prostate cancer cells.
    Wang C; Ke Y; Liu S; Pan S; Liu Z; Zhang H; Fan Z; Zhou C; Liu J; Wang F
    J Biol Chem; 2018 Sep; 293(38):14839-14849. PubMed ID: 30093411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STIM1 accelerates cell senescence in a remodeled microenvironment but enhances the epithelial-to-mesenchymal transition in prostate cancer.
    Xu Y; Zhang S; Niu H; Ye Y; Hu F; Chen S; Li X; Luo X; Jiang S; Liu Y; Chen Y; Li J; Xiang R; Li N
    Sci Rep; 2015 Aug; 5():11754. PubMed ID: 26257076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An ATM/TRIM37/NEMO Axis Counteracts Genotoxicity by Activating Nuclear-to-Cytoplasmic NF-κB Signaling.
    Wu G; Song L; Zhu J; Hu Y; Cao L; Tan Z; Zhang S; Li Z; Li J
    Cancer Res; 2018 Nov; 78(22):6399-6412. PubMed ID: 30254148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathways: involving microenvironment damage responses in cancer therapy resistance.
    Sun Y; Nelson PS
    Clin Cancer Res; 2012 Aug; 18(15):4019-25. PubMed ID: 22619305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity.
    Domingo-Domenech J; Oliva C; Rovira A; Codony-Servat J; Bosch M; Filella X; Montagut C; Tapia M; Campás C; Dang L; Rolfe M; Ross JS; Gascon P; Albanell J; Mellado B
    Clin Cancer Res; 2006 Sep; 12(18):5578-86. PubMed ID: 17000695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells provide an advantageous tumor microenvironment for the restoration of cancer stem cells.
    Nishimura K; Semba S; Aoyagi K; Sasaki H; Yokozaki H
    Pathobiology; 2012; 79(6):290-306. PubMed ID: 22688186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone receptor membrane component 1 leads to erlotinib resistance, initiating crosstalk of Wnt/β-catenin and NF-κB pathways, in lung adenocarcinoma cells.
    Lin Y; Higashisaka K; Shintani T; Maki A; Hanamuro S; Haga Y; Maeda S; Tsujino H; Nagano K; Fujio Y; Tsutsumi Y
    Sci Rep; 2020 Mar; 10(1):4748. PubMed ID: 32179851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
    Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
    Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapeutic resistance: surviving stressful situations.
    Gilbert LA; Hemann MT
    Cancer Res; 2011 Aug; 71(15):5062-6. PubMed ID: 21771909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via Wnt/β-catenin signaling pathway.
    Hu K; Gu Y; Lou L; Liu L; Hu Y; Wang B; Luo Y; Shi J; Yu X; Huang H
    J Hematol Oncol; 2015 Jan; 8():1. PubMed ID: 25622682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal hematopoiesis and hematologic malignancies: role of canonical Wnt signaling pathway and stromal microenvironment.
    Seke Etet PF; Vecchio L; Bogne Kamga P; Nchiwan Nukenine E; Krampera M; Nwabo Kamdje AH
    Biochim Biophys Acta; 2013 Jan; 1835(1):1-10. PubMed ID: 22982245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated Wnt/β-Catenin signaling contributes to E3 ubiquitin ligase EDD-conferred docetaxel resistance in prostate cancer.
    Bian P; Dou Z; Jia Z; Li W; Pan D
    Life Sci; 2020 Aug; 254():116816. PubMed ID: 31472148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.